GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TMS Co Ltd (TSE:4891) » Definitions » Capex-to-Revenue

TMS Co (TSE:4891) Capex-to-Revenue : 0.00 (As of Nov. 2023)


View and export this data going back to 2022. Start your Free Trial

What is TMS Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

TMS Co's Capital Expenditure for the three months ended in Nov. 2023 was 円0.00 Mil. Its Revenue for the three months ended in Nov. 2023 was 円0.00 Mil.

GuruFocus do not calculate Capex-to-Revenue if the revenue is negative.


TMS Co Capex-to-Revenue Historical Data

The historical data trend for TMS Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TMS Co Capex-to-Revenue Chart

TMS Co Annual Data
Trend Feb21 Feb22 Feb23
Capex-to-Revenue
- 0.01 -

TMS Co Quarterly Data
Feb21 Feb22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
Capex-to-Revenue Get a 7-Day Free Trial - - - - -

Competitive Comparison of TMS Co's Capex-to-Revenue

For the Biotechnology subindustry, TMS Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TMS Co's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TMS Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where TMS Co's Capex-to-Revenue falls into.



TMS Co Capex-to-Revenue Calculation

TMS Co's Capex-to-Revenue for the fiscal year that ended in Feb. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-13.721) / 0
=N/A

TMS Co's Capex-to-Revenue for the quarter that ended in Nov. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TMS Co  (TSE:4891) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


TMS Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of TMS Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


TMS Co (TSE:4891) Business Description

Traded in Other Exchanges
N/A
Address
1-9 Fuchu-cho, Fuchu-shi, Keio Fuchu 1-chome building 11th floor, Tokyo, JPN, 183-0055
TMS Co Ltd is engaged in the research and development of pharmaceuticals, quasi-drugs, pharmaceutical raw materials, medical equipment and medical consumables.

TMS Co (TSE:4891) Headlines

No Headlines